Growth hormone as an immunomodulating therapeutic agent.
Murphy
W J
WJ
National Cancer Institute-Frederick Cancer Research and Development, Frederick, MD, USA.
Longo
D L
DL
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000502:physiology*; D000818:Animals; D018771:Arthralgia / Q000139:chemically induced; D013006:Growth Hormone / Q000009:adverse effects / Q000502:physiology*; D016298:Hematopoietic Cell Growth Factors / Q000009:adverse effects / Q000502:physiology*; D006801:Humans; D018960:Hyaluronan Receptors / Q000276:immunology; D051379:Mice; D010865:Pilot Projects; D020395:Receptors, Interleukin-7 / Q000276:immunology; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D013950:Thymus Gland / Q000187:drug effects / Q000276:immunology
D000276:Adjuvants, Immunologic; D016298:Hematopoietic Cell Growth Factors; D018960:Hyaluronan Receptors; D020395:Receptors, Interleukin-7; D013006:Growth Hormone